Paul Tudor Jones’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
18,800
+15,700
+506% +$1.27M ﹤0.01% 2103
2026
Q1
$219K Sell
3,100
-4,600
-60% -$344K ﹤0.01% 3326
2025
Q4
$608K Sell
7,700
-38,300
-83% -$3.03M ﹤0.01% 2602
2025
Q3
$3.79M Sell
46,000
-6,600
-13% -$519K 0.01% 1384
2025
Q2
$4.23M Buy
52,600
+46,300
+735% +$3.57M 0.01% 1190
2025
Q1
$506K Sell
6,300
-13,800
-69% -$1.15M ﹤0.01% 2277
2024
Q4
$1.65M Buy
+20,100
New +$1.67M 0.01% 1384
2024
Q2
Sell
-2,800
Closed -$208K 2600
2024
Q1
$208K Sell
2,800
-17,800
-86% -$1.24M ﹤0.01% 2033
2023
Q4
$1.36M Buy
20,600
+17,400
+544% +$1.09M 0.01% 1299
2023
Q3
$201K Sell
3,200
-27,500
-90% -$1.71M ﹤0.01% 2091
2023
Q2
$1.74M Buy
+30,700
New +$1.7M 0.02% 972

Other funds holding MET

Paul Tudor Jones's MET Position: Q2 2026 in Review

Paul Tudor Jones sold out of MetLife (MET) in Q2 2026, closing a stake of 70,474 shares — an estimated $5.68M sold.

Paul Tudor Jones first reported a position in MET in Q3 2014 and held it in 33 quarters. The position peaked at $31.5M in Q2 2023. 1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Paul Tudor Jones reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 70,474 MetLife shares in Q2 2026, an estimated $5.68M.
  • Paul Tudor Jones first reported a position in MetLife in Q3 2014 and held it in 33 quarters.
  • Paul Tudor Jones's MetLife position peaked at $31.5M in Q2 2023.
  • 1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.